Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Spacer Graft Study

NCT: NCT04140734 · RECRUITING

NCT IDNCT04140734
StatusRECRUITING
Start Date2021-08-01
Completion2028-07

Brief Summary

To determine which of three types of spacer grafts (hard palate vs autologous ear cartilage vs Enduragen) are the most effective in lower eyelid retraction repair outcomes as measured by MRD2 (margin to reflex distance 2)

Frequently Asked Questions

What is Spacer Graft Study?

Spacer Graft Study is a clinical trial registered under NCT04140734. Current status: RECRUITING.

What is the status of NCT04140734?

The current status of NCT04140734 (Spacer Graft Study) is: RECRUITING.

When did Spacer Graft Study start?

Spacer Graft Study started on 2021-08-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.